StimCardio CEO Amir Soltanianzadeh named to Cardiovascular Business Forty Under 40

Written By john paskin

20 March 2026 — Cardiovascular Business has named StimCardio CEO Amir Soltanianzadeh to its Forty Under 40 Class of 2026. The publication notes he is developing what the company describes as the world’s first wearable device capable of both detecting and non-invasively treating atrial fibrillation through neuromodulation.

Source: https://cardiovascularbusiness.com/topics/healthcare-management/leadership/cardiovascular-business-announces-its-forty-under-40-class-2026

Albion Trinity Capital is an investor in StimCardio.

john paskin
Previous

ChillSkyn secures seed acceleration round with Cycle Momentum and New York Angels
Next

Surgical robotics pioneer Dr Yulun Wang joins AiM Medical Robotics board